Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med 2014 Nov 13;371(20):1877-88 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/25265492.
Compare quality appraisals for each clinical question
- Does systemic drug therapy improve progression-free, overall survival in unresectable stage III and stage IV melanoma?